Endocannabinoid System & Teen Anxiety: Clinical Evidence
Internalising symptoms adolescent cannabis use is linked to increased risk of initiation and escalation among teens. This clinical evidence highlights the importance of screening for anxiety and depression in adolescents. Understanding these risks can…
Endocannabinoid System & Trauma Sleep Research Insights
Pre-trauma insomnia and substance use are linked in trauma survivors, increasing risk for problematic alcohol and cannabis use. Early posttraumatic stress symptoms partially mediate this relationship. Addressing sleep disturbances may reduce substance…
Trauma-Focused Treatment and Cannabis Use in PTSD Care
Trauma-focused treatment PTSD cannabis use remains effective even with co-occurring substance use disorders. Cannabis use does not reduce the benefits of trauma-focused psychotherapy. This insight supports maintaining evidence-based PTSD care protocols.
Cannabinoids for Children: Clinical Evidence Reviewed
Current cannabinoids pediatric safety evidence spans 276 studies covering plant-derived and pharmaceutical formulations for children under 18. This clinical review synthesizes safety and reported benefits from interventional trials and observational…
VER-01 Cannabis Extract: Phase 3 Trial for Chronic Back Pain
The VER-01 cannabis extract clinical trial evaluated 820 adults with chronic low back pain in a rigorous phase 3 study. Results demonstrated significant pain reduction and a favorable safety profile. This trial adds important clinical evidence for…
Endocannabinoid System: Cannabis for Chronic Pain Review
Cannabis-based products for chronic pain clinical evidence shows modest but measurable reductions in pain severity compared to placebo. The quality of evidence varies by THC-to-CBD ratio, product type, and delivery method. Patients and clinicians should…
Review of Cannabinoids Safety and Efficacy in Pediatric Care
This review focuses on cannabinoids pediatric safety efficacy in clinical use, highlighting condition-specific evidence. Research supports cautious use in epilepsy and pain management among children. Clinicians should consider evolving data to guide…
Endocannabinoid System & Cannabis for Chronic Back Pain Trial
This phase 3 full-spectrum cannabis extract trial evaluated VER-01 for chronic low back pain in 820 adults. The study demonstrated significant pain reduction and good tolerability. These results support the potential of cannabis extract as an alternative…
Cannabinoid Efficacy in Chronic Pain: Updated Clinical Evidence
Clinical trials demonstrate cannabinoid efficacy chronic pain with modest reductions compared to placebo. The THC-to-CBD ratio and administration method influence outcomes. Patients and clinicians should consider these factors carefully.
Endocannabinoid System & PTSD: Cannabis in Dual Diagnosis
Cannabis use and trauma-focused treatment are critical considerations in managing PTSD with co-occurring substance use disorders. Evidence shows trauma-focused treatments remain effective despite cannabis use. This supports continuing evidence-based care…
